Our attorneys and staff continue to work through COVID-19 and remain available 24/7, ready to fight for you. Our video conferencing, case management, and telecommunications systems allow us to stay in constant contact with our clients and pursue their claims without interruption – all without our clients leaving the comfort of their homes. You focus on staying healthy and safe, we’re here to handle the rest.
Novo Nordisk Inc. is issuing a recall on six batches of their hypoglycemia kit, GlucaGen HypoKit, due to the needles detaching from the syringe, rendering the treatment unusable.
About the Novo Nordisk GlucaGen HypoKit Recall
According to the U.S. Food and Drug Administration (FDA), two reports of needle detachment out of the United Kingdom and Portugal prompted Novo Nordisk to issue the recall.
Through an investigation, Novo Nordisk found that a very small number of syringes may actually contain defects, an estimated four out of 71,215.
However, if a consumer cannot treat their hypoglycemia due to an unusable product, it could lead to unconsciousness or seizures, which can be fatal.
Patients and caregivers are advised to check the batch number of their GlucaGen HypoKit to see if it is part of the recall. If so, contact the company at 1-800-840-1137 to find out how to return the product.
Description of the Recalled GlucaGen HypoKit
The recall includes six batches, including the following batch numbers: